|
CX157 (proposed trade name TriRima, formerly Tyrima) is a selective and reversible inhibitor of MAO-A (RIMA). As of 2007 it was in phase II clinical trials for the treatment of depression. == See also == * Reversible inhibitor of MAO-A (RIMA) * Monoamine oxidase inhibitor (MAOI) 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「CX157」の詳細全文を読む スポンサード リンク
|